These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 37221456)

  • 1. Effects of (non)deceptive placebos on reported sleep quality and food cue reactivity.
    Potthoff J; Schienle A
    J Sleep Res; 2024 Apr; 33(2):e13947. PubMed ID: 37221456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deceptive but not open label placebos attenuate motion-induced nausea.
    Barnes K; Yu A; Josupeit J; Colagiuri B
    J Psychosom Res; 2019 Oct; 125():109808. PubMed ID: 31426018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can observational learning reinforce open-label placebo hypoalgesia?
    Brączyk J; Bąbel P
    Pain; 2024 Jul; 165(7):1605-1612. PubMed ID: 38227574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prescribing Placebos: An Experimental Examination of the Role of Dose, Expectancies, and Adherence in Open-Label Placebo Effects.
    El Brihi J; Horne R; Faasse K
    Ann Behav Med; 2019 Jan; 53(1):16-28. PubMed ID: 29547962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deceptive and open-label placebo effects in experimentally induced guilt: a randomized controlled trial in healthy subjects.
    Sezer D; Locher C; Gaab J
    Sci Rep; 2022 Dec; 12(1):21219. PubMed ID: 36481801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Placebo Effects on Visual Food Cue Reactivity: An Eye-Tracking Investigation.
    Potthoff J; Jurinec N; Schienle A
    Front Psychiatry; 2019; 10():525. PubMed ID: 31396116
    [No Abstract]   [Full Text] [Related]  

  • 7. Remotely administered non-deceptive placebos reduce COVID-related stress, anxiety, and depression.
    Guevarra DA; Webster CT; Moros JN; Kross E; Moser JS
    Appl Psychol Health Well Being; 2024 Aug; ():. PubMed ID: 39143695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is the rationale more important than deception? A randomized controlled trial of open-label placebo analgesia.
    Locher C; Frey Nascimento A; Kirsch I; Kossowsky J; Meyer A; Gaab J
    Pain; 2017 Dec; 158(12):2320-2328. PubMed ID: 28708766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imaginary pills and open-label placebos can reduce test anxiety by means of placebo mechanisms.
    Buergler S; Sezer D; Bagge N; Kirsch I; Locher C; Carvalho C; Gaab J
    Sci Rep; 2023 Feb; 13(1):2624. PubMed ID: 36788309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Open-label nondeceptive placebo analgesia is blocked by the opioid antagonist naloxone.
    Benedetti F; Shaibani A; Arduino C; Thoen W
    Pain; 2023 May; 164(5):984-990. PubMed ID: 36165878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Open-label Placebos for Wound Healing: A Randomized Controlled Trial.
    Mathur A; Jarrett P; Broadbent E; Petrie KJ
    Ann Behav Med; 2018 Sep; 52(10):902-908. PubMed ID: 30212845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of open-label and deceptive placebo analgesia in a healthy sample.
    Disley N; Kola-Palmer S; Retzler C
    J Psychosom Res; 2021 Jan; 140():110298. PubMed ID: 33227553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Appearances are not deceptive: clinical evidence and new research approaches to open-label placebo].
    Nestoriuc Y; Kleine-Borgmann J
    Nervenarzt; 2020 Aug; 91(8):708-713. PubMed ID: 32691079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of prolonged release melatonin in insomnia patients aged 55-80 years: quality of sleep and next-day alertness outcomes.
    Wade AG; Ford I; Crawford G; McMahon AD; Nir T; Laudon M; Zisapel N
    Curr Med Res Opin; 2007 Oct; 23(10):2597-605. PubMed ID: 17875243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 'It's not my greengrocer, it's someone from the medical profession': A qualitative study regarding acceptability of deceptive and open-label placebo prescribing in France.
    Druart L; Vauthrin O; Pinsault N; Locher C; Blease C
    Br J Health Psychol; 2023 May; 28(2):273-290. PubMed ID: 36086862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of positive information provision in open-label placebo effects.
    Barnes K; Babbage E; Barker J; Jain N; Faasse K
    Appl Psychol Health Well Being; 2023 Nov; 15(4):1406-1426. PubMed ID: 36932997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. If only they knew! A non-inferiority randomized controlled trial comparing deceptive and open-label placebo in healthy individuals.
    Druart L; Graham Longsworth SE; Terrisse H; Locher C; Blease C; Rolland C; Pinsault N
    Eur J Pain; 2024 Mar; 28(3):491-501. PubMed ID: 37965922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Why do open-label placebos work? A randomized controlled trial of an open-label placebo induction with and without extended information about the placebo effect in allergic rhinitis.
    Schaefer M; Sahin T; Berstecher B
    PLoS One; 2018; 13(3):e0192758. PubMed ID: 29513699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Placebos in primary care? a nominal group study explicating UK GP and patient views of six theoretically plausible models of placebo practice.
    Ratnapalan M; Coghlan B; Tan M; Everitt H; Geraghty AWA; Little P; Lewith G; Bishop FL
    BMJ Open; 2020 Feb; 10(2):e032524. PubMed ID: 32075826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of patient beliefs in open-label placebo effects.
    Leibowitz KA; Hardebeck EJ; Goyer JP; Crum AJ
    Health Psychol; 2019 Jul; 38(7):613-622. PubMed ID: 31021124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.